EB-2 NIWBiotech and pharmaEmployerDecided July 2024Dismissed
Outcome: Dismissed
JUL102024_11B5203
Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed
Our summary
A pharmaceutical industrial production manager sought EB-2 classification with national interest waiver to plan and direct manufacturing operations. The AAO found the proposed endeavor had substantial merit but lacked national importance, as providing services for one employer would not generate significant economic activity or employment potential at national scale.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
No criterion in the table was found met in this decision.
What was missing
- Merit and national importance · Proposed endeavor as single pharmaceutical production manager lacks national importance; petitioner provided only vague assertions about drug shortage mitigation without demonstrating broader industry impact or specific economic benefits.
Criteria
| Criterion | Reading | Why |
|---|---|---|
 Merit and national importance | Not met | Proposed endeavor as single pharmaceutical production manager lacks national importance; petitioner provided only vague assertions about drug shortage mitigation without demonstrating broader industry impact or specific economic benefits. |
 Well positioned | Not reached / not discussed | Not reached because first prong failed; decision explicitly reserved this issue. |
 Balance favors a waiver | Not reached / not discussed | Not reached because first prong failed; decision explicitly reserved this issue. |
A published decision describes one case. It is not legal advice and not a prediction for yours.